Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer (Q34381481)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

0 references

author name string

K D Crew

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

K A Ho

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

P Brown

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

H Greenlee

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

T B Bevers

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

B Arun

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

N Sneige

7

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

C Hudis

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

H L McArthur

9

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

J Chang

10

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

M Rimawi

11

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

T L Cornelison

12

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

J Cardelli

13

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

R M Santella

14

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A Wang

15

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

S M Lippman

16

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

D L Hershman

17

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

19 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Journal of Human Nutrition and Dietetics

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

272-282

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of polyphenon E in women with hormone receptor-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

cMET and phospho-cMET protein levels in breast cancers and survival outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Effect of 2-month controlled green tea intervention on lipoprotein cholesterol, glucose, and hormone levels in healthy postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Genetic Association Between the COMT Genotype and Urinary Levels of Tea Polyphenols and Their Metabolites among Daily Green Tea Drinkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Green tea improves metabolic biomarkers, not weight or body composition: a pilot study in overweight breast cancer survivors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Green tea consumption and breast cancer risk or recurrence: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

(-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Proposed mechanisms of (-)-epigallocatechin-3-gallate for anti-obesity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Met, metastasis, motility and more

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

6 July 2018

Genotoxicity and toxicity of the potential cancer-preventive agent polyphenon E.

1 reference

https://api.crossref.org/works/10.1111/JHN.12229

21 January 2018

Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in A/J mice by oral administration of green tea.

1 reference

https://api.crossref.org/works/10.1111/JHN.12229

21 January 2018

Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction.

1 reference

https://api.crossref.org/works/10.1111/JHN.12229

21 January 2018

Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth facto

1 reference

https://api.crossref.org/works/10.1111/JHN.12229

21 January 2018

Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer

1 reference

https://api.crossref.org/works/10.1111/JHN.12229

21 January 2018

Repletion of antioxidant status by EGCG and retardation of oxidative damage induced macromolecular anomalies in aged rats

1 reference

https://api.crossref.org/works/10.1111/JHN.12229

21 January 2018

Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies

1 reference

https://api.crossref.org/works/10.1111/JHN.12229

21 January 2018

Chronic green tea extract supplementation reduces hemodialysis-enhanced production of hydrogen peroxide and hypochlorous acid, atherosclerotic factors, and proinflammatory cytokines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

27 October 2018

Effect of Increased Tea Consumption on Oxidative DNA Damage among Smokers: A Randomized Controlled Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

27 October 2018

Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4205214

27 October 2018

Protein carbonyl measurement by enzyme-linked immunosorbent assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/24646362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between urinary 15-F2t-isoprostane and 8-oxodeoxyguanosine levels and breast cancer risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/24646362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential designs for phase I clinical trials with late-onset toxicities

1 reference

https://pubmed.ncbi.nlm.nih.gov/24646362

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/JHN.12229

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34381481&oldid=1979889047"